NGFR+ stromal cells were enriched at early time points following tumor injection in mice and were more abundant in smaller human tumors, supporting a model in which stromal NGFR/NGFR expression declines as tumor invasion advances and desmoplastic stroma develops. The gene discussed is NGFR; the disease is neoplasm.